BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12097147)

  • 1. A novel link between the proteasome pathway and the signal transduction pathway of the bone morphogenetic proteins (BMPs).
    Lin Y; Martin J; Gruendler C; Farley J; Meng X; Li BY; Lechleider R; Huff C; Kim RH; Grasser WA; Paralkar V; Wang T
    BMC Cell Biol; 2002 Jun; 3():15. PubMed ID: 12097147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasomal degradation of Smad1 induced by bone morphogenetic proteins.
    Gruendler C; Lin Y; Farley J; Wang T
    J Biol Chem; 2001 Dec; 276(49):46533-43. PubMed ID: 11571290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic growth induced by BMP-7 requires Smad1 and proteasome activity.
    Guo X; Lin Y; Horbinski C; Drahushuk KM; Kim IJ; Kaplan PL; Lein P; Wang T; Higgins D
    J Neurobiol; 2001 Aug; 48(2):120-30. PubMed ID: 11438941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SANE, a novel LEM domain protein, regulates bone morphogenetic protein signaling through interaction with Smad1.
    Raju GP; Dimova N; Klein PS; Huang HC
    J Biol Chem; 2003 Jan; 278(1):428-37. PubMed ID: 12393873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHIP mediates degradation of Smad proteins and potentially regulates Smad-induced transcription.
    Li L; Xin H; Xu X; Huang M; Zhang X; Chen Y; Zhang S; Fu XY; Chang Z
    Mol Cell Biol; 2004 Jan; 24(2):856-64. PubMed ID: 14701756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis.
    Katagiri T; Imada M; Yanai T; Suda T; Takahashi N; Kamijo R
    Genes Cells; 2002 Sep; 7(9):949-60. PubMed ID: 12296825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of Smads and related transcription factors in the signal transduction of bone morphogenetic protein inducing bone formation].
    Xu XL; Dai KR; Tang TT
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 Sep; 17(5):359-62. PubMed ID: 14551929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.
    Itoh F; Asao H; Sugamura K; Heldin CH; ten Dijke P; Itoh S
    EMBO J; 2001 Aug; 20(15):4132-42. PubMed ID: 11483516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse smad8 phosphorylation downstream of BMP receptors ALK-2, ALK-3, and ALK-6 induces its association with Smad4 and transcriptional activity.
    Kawai S; Faucheu C; Gallea S; Spinella-Jaegle S; Atfi A; Baron R; Roman SR
    Biochem Biophys Res Commun; 2000 May; 271(3):682-7. PubMed ID: 10814522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-beta signal transduction.
    Kim RH; Wang D; Tsang M; Martin J; Huff C; de Caestecker MP; Parks WT; Meng X; Lechleider RJ; Wang T; Roberts AB
    Genes Dev; 2000 Jul; 14(13):1605-16. PubMed ID: 10887155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction.
    Aoki H; Fujii M; Imamura T; Yagi K; Takehara K; Kato M; Miyazono K
    J Cell Sci; 2001 Apr; 114(Pt 8):1483-9. PubMed ID: 11282024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Smad pathway.
    Wrana JL; Attisano L
    Cytokine Growth Factor Rev; 2000; 11(1-2):5-13. PubMed ID: 10708948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of Smad1-mediated transcription by p300/CBP.
    Pearson KL; Hunter T; Janknecht R
    Biochim Biophys Acta; 1999 Dec; 1489(2-3):354-64. PubMed ID: 10673036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene.
    López-Rovira T; Chalaux E; Massagué J; Rosa JL; Ventura F
    J Biol Chem; 2002 Feb; 277(5):3176-85. PubMed ID: 11700304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12.
    Nishimura R; Kato Y; Chen D; Harris SE; Mundy GR; Yoneda T
    J Biol Chem; 1998 Jan; 273(4):1872-9. PubMed ID: 9442019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone morphogenetic protein-2 (BMP-2) transactivates Dlx3 through Smad1 and Smad4: alternative mode for Dlx3 induction in mouse keratinocytes.
    Park GT; Morasso MI
    Nucleic Acids Res; 2002 Jan; 30(2):515-22. PubMed ID: 11788714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2.
    Macías-Silva M; Hoodless PA; Tang SJ; Buchwald M; Wrana JL
    J Biol Chem; 1998 Oct; 273(40):25628-36. PubMed ID: 9748228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation.
    Harada J; Kokura K; Kanei-Ishii C; Nomura T; Khan MM; Kim Y; Ishii S
    J Biol Chem; 2003 Oct; 278(40):38998-9005. PubMed ID: 12874272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular signaling of osteogenic protein-1 through Smad5 activation.
    Tamaki K; Souchelnytskyi S; Itoh S; Nakao A; Sampath K; Heldin CH; ten Dijke P
    J Cell Physiol; 1998 Nov; 177(2):355-63. PubMed ID: 9766532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.